前收市價 | 1.0200 |
開市 | 1.0400 |
買盤 | 1.0300 x 1000 |
賣出價 | 1.0600 x 1000 |
今日波幅 | 0.9754 - 1.0600 |
52 週波幅 | 0.3330 - 19.4700 |
成交量 | |
平均成交量 | 2,774,104 |
市值 | 102.722M |
Beta 值 (5 年,每月) | 0.74 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -2.9200 |
業績公佈日 | 2024年5月06日 - 2024年5月10日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 1.75 |
Vertex (VRTX) signs a collaboration agreement with TreeFrog to utilize the latter's C-Stem technology in order to optimize the production of its T1D cell therapies.
Ultragenyx (RARE) reports positive interim data from the phase I/II study of GTX-102 for Angelman syndrome. However, the stock declines due to safety concerns.
Xilio (XLO) rallies 79.8% in a month on an exclusive global licensing agreement with Gilead Sciences to develop XTX301 for advanced solid tumors.